Forxiga CKD Japan Post-Marketing Surveillance (PMS)

Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease

NCT06527846 ·Status: ACTIVE_NOT_RECRUITING

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

NCT06929156 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

NCT01030679 ·Status: COMPLETED ·Phase: PHASE2

A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

NCT01572610 ·Status: TERMINATED ·Phase: PHASE2

A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)

NCT01986855 ·Status: COMPLETED ·Phase: PHASE3

Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

NCT07116928 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein

NCT05922852 ·Status: UNKNOWN

Therapeutic Drug Use for CKD Patients

NCT05818995 ·Status: UNKNOWN

Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease

NCT05196347 ·Status: COMPLETED ·Phase: PHASE3

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

NCT05942625 ·Status: RECRUITING ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects

NCT05544214 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

NCT01064414 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of AZD5672 in Renally Impaired Subjects

NCT00715702 ·Status: COMPLETED ·Phase: PHASE1

Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients

NCT06203704 ·Status: COMPLETED

Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment

NCT06547502 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

NCT02065791 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

NCT02010242 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

NCT03616392 ·Status: COMPLETED ·Phase: PHASE1

JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)

NCT06287073 ·Status: COMPLETED

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

NCT02316821 ·Status: COMPLETED ·Phase: PHASE2

SGLT2 Inhibitors and Renal Anemia in Japan: RWD

NCT07063316 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

NCT01464320 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes

NCT06415214 ·Status: COMPLETED ·Phase: PHASE2

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

NCT04285983 ·Status: COMPLETED

A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

NCT01574365 ·Status: TERMINATED ·Phase: PHASE2